New Paper on Digital Endpoints in Alzheimer’s Disease and other Neurodegenerative Diseases

New paper out! Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities by Brem et al.

The publication draws on findings and lessons learned from three IMI initiatives, RADAR-AD, IDEA-FAST and Mobilise-D to discuss:

  • The value of remote technologies to assess neurodegenerative diseases
  • Feasibility, acceptability and usability of digital assessments
  • Challenges related to the use of digital tools
  • Public involvement and the implementation of patient advisory boards
  • Regulatory learnings
  • The significance of inter-project exchange and data- and algorithm-sharing

To read the paper follow the link: